Investors & Media

Transformative science, targeted medicines

Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

SEC filing details

Document Details

Form
S-1/A
Filing Date
Apr 20, 2015
Document Date
Apr 20, 2015
Form Description
Amended Registration statement for face-amount certificate companies
Filing Group
Registration Statements
Company
Blueprint Medicines Corp.
Issuer
Blueprint Medicines Corp